1. JY Park, CO Chong, HS Han, D Chung. YH Lee, DG Hong, J-Y Park et al. Intrutumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer. (2021) European journal of surgical oncology.
2. NJ Park, JY Jeong, J-Y Park, HJ Kim, CS Park, J Lee, HY Park, JH Jung, WW Kim, YS Chae, SJ Lee, WH Kim. Peitumoral Edema in Breast Cancer at Preoperative MRI: an Interpretative Study with Histopathological Reivew toward Understanding Tumor Microenvironment. (2021) Scientific Reports
3. HS Kim, JS Yoon, Y Jeon , EJ Park, JK Lee, S Chen, H Lee, JY Park, H Go, CW Lee. Ssu72-HNF4α Signaling Axis Classify the Transition From Steatohepatitis To 2 Hepatocellular Carcinoma. (2021) Cell Death and Differentiation.
4. JY Park, CO Chong, J-Y Park. D Chung. YH Lee, HJ Lee, DG Hong, HS Han, YS Lee. Tumor budding in cervical cancer as a prognostic factor and its possible value as an additional intermediate-risk factor. (2020) Gynecologic oncology
5. JY Park, PJ Kim, SJ Shin, JL Lee, YM Cho, H Go. (2020, Epub ahead of print) FGFR1 Is Associated with c-MYC and Proangiogenic Molecules in Metastatic Renal Cell Carcinoma under Anti-Angiogenic Therapy. (2020) Histopathology.
6. JW Chung, JY Park, H Ha, KB Park, Y-S Ha, SH Choi, JN Lee, BS Kim, HT Kim, TH Kim, ES Yoo, SK Chung, GS Yoon, TG Kwon. A Rare Pericytic Tumor of the Kidney: The First Case in Korea. (2020) International Journal of Surgery Case Reports.
7. J Min, LK Chin, J Oh, C Landeros, C Vinegoni, J Lee, SJ Lee, JY Park, A-Q Liu, CM Castro, H Lee, H Im, R Weissleder. CytoPAN
Portable cellular analyses for rapid point-of-care cancer diagnosis. (2020) Science Translational Medicine.
8. DW Baek, JY Park, SJ Lee, YS Chae. The Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Relapsed Ectopic Male Breast Cancer. (2020) J Breast Cancer.
9. CS Park, HY Park, JH Jung, WW Kim, YS Chae, SJ Lee, J-Y Park, JY Park, J Lee. Comparison of Clinical Features and Oncologic Outcomes between Familial (Non-Hereditary) and Hereditary Breast Cancer in Korean Female Patients. (2020) Asian Journal of Surgery.
10. J-Y Park, DG Hong, GO Chong, JY Park. Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma. (2019) Pathology & Oncology Research.
11. JY Park, DG Hong, J-Y Park. Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma. (2019) Pathology & Oncology Research.
12. CS Park, JY Park. Optimal Safe Staffing Standard for Right Workforce Planning. (2019) Journal of Learning and Teaching in Digital Age.
13. H Go, MJ Kang, PJ Kim, JL Lee, JY Park, JM Park, JY Ro, YM Cho. Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma. (2019) Pathology & Oncology Research.
14. YR Park, J Lee, JH Jung, WW Kim, CS Park, RK Lee, YS Chae, SJ Lee, J-Y Park, JY Park, HY Park. Absence of Estrogen Receptor Is Associated with Worse Oncologic Outcome in Patients Who Were Received Neoadjuvant Chemotherapy for Breast Cancer. (2019) Asian Journal of Surgery.
15. J Lee, WH Kim, JH Jung, WW Kim, CS Park, RK Lee, JY Park, YS Chae, SJ Lee, HJ Kim, J-Y Park, HY Park. Clinical Validation of BCT Scores with Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer. (2019) In Vivo.
16. J Lee, EH Lee, HY Park, WW Kim, RK Lee, YS Chae, SJ Lee, JE Kim, B Kang, JY Park, J-Y Park, JH Jung. Efficacy of an RNA-based Multigene Assay with Core Needle Biopsy Samples for Risk Evaluation in Hormone-Positive Early Breast Cancer. (2019) BMC Cancer.
17. JY Park, JH Lee, KB Song, DW Hwang, K-R Kim, SC Kim, S-M Hong. Significance of Microcystic, Elongated, and Fragmented Glandular-like Features in Intraductal Papillary Mucinous Neoplasm of the Pancreas. (2018) Human Pathology.
18. JY Park, GS Yoon. Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma. (2017) Pathology & Oncology Research.
19. JY Park, J-Y Park, J-H Nam, K-R Kim. Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium. (2017) International Journal of Gynecological Pathology.
20. J Oh, KH Seol, HJ Lee, YS Choi, JY Park, JY Bae. Prophylactic Extended-Field Irradiation with Concurrent Chemotherapy for Pelvic Lymph Node-Positive Cervical Cancer. (2017) Journal of Radiation Oncology.
21. WH Kim, HJ An, JY Kim, MG Gwon, H Gu, SJ Lee, JY Park, KD Park, SM Han, MK Kim, KK Park. Apamin Inhibits TNF-a- and IFN-
-Induced Inflammatory Cytokines and Chemokines via Suppressions of NF-kB Signaling Pathway and STAT in Human Keratinocytes. (2017) Pharmacological Reports.
22. J Park, HY Park, S Kim, HS Kim, JY Park, H Go, C-W Lee. Pellino 1 Inactivates Mitotic Spindle Checkpoint by Targeting BubR1 for Ubiquitinational Degradation. (2017) Oncotarget.
23. SJ Lee, JY Park. A Rare Case of Intramural Mullerian Adenosarcoma Arising from Adenomyosis of the Uterus. (2017) Journal of Pathology and Translational Medicine.
24. HS Lee, WH Kim, Y Kwak, J Koh, JM Bae, KM Kim, MS Chang, HS Han, JM Kim, HW Kim, HK Chang, YH Choi, JY Park, MJ Gu1, MJ Lhee, JY Kim, HS Kim, MY Cho. (2017) Molecular Testing for Gastrointestinal Cancer. Journal of Pathology and Translational Medicine.
25. PJ Kim, JY Park, HG Kim, YM Cho, H Go. Dishevelled Segment Polarity Protein 3 (DVL3): a Novel and Easily Applicable Recurrence Predictor in Localised Prostate Adenocarcinoma. (2017) BJU International.
26. Kwon, KD Park, H Chung, JB Park, JY Park, DH Shin, J Park. A Case of Primary Cutaneous Langerhans Cell Sarcoma Clinically Mimicking Pyogenic Granuloma. (2017) The Hong Kong Journal of Dermatology and Venereology.
27. JY Park, MH Ryu, YS Park, HJ Park, BY Ryoo, MG Kim, JH Yook, BS Kim, YK Kang. Prognostic Significance of Neuroendocrine Components in Gastric Carcinomas. (2014) European Journal of Cancer.
28. JY Park, JL Lee, S Baek, SH Eo, H Go, JY Ro, YM Cho. Sarcomatoid Features, Necrosis, and Grade are Prognostic Factors in Metastatic Clear Cell Renal Cell Carcinoma with Vascular Endothelial Growth Factor
Targeted Therapy. (2014) Human Pathology.
29. JY Park, M Choe, Y Kang, SS Lee. IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma. (2014) The Korean Journal of Pathology.
30. JY Park, CO Sung, SJ Jang, SY Song, JH Han, K-R Kim. Pulmonary Netastatic Nodules of Uterine Low-Grade Endometrial Stromal Sarcoma: Histopathological and Immunohistochemical Analysis of 10 Cases. (2013) Histopathology.
31. JY Park, JH Nam, YT Kim, YM Kim, JH Kim, DY Kim, I Sohn, SW Lee, CO Sung, K-R Kim. Poor Prognosis of Uterine Serous Carcinoma Compared with Grade 3 Endometrioid Carcinoma in Early Stage Patients. (2013) Virchows Archive.
32. JY Park, WY Kim, TS Hwang, SS Lee, H Kim, HS Han, SD Lim, WS Kim, YB Yoo, KS Park. BRAF and RAS Mutations in Follicular Variants of Papillary Thyroid Carcinoma. (2013) Endocrine Pathology.
33. JY Park, E Kim, DW Kim, HW Chang, SP Kim. Cribriform Neuroepithelial Tumor in the Third Ventricle: A Case Report and Literature Review. (2012) Neuropathology.
34. JY Park, NJ Park, SP Kim, KY Kwon, SS Lee. A Soft Tissue Perineurioma and a Hybrid Tumor of Perineurioma and Schwannoma. (2012) The Korean Journal of Pathology.
35. JY Park, H Park, NJ Park, JS Park, HJ Sung, SS Lee. Use of Calretinin, CD56, and CD34 for Differential Diagnosis of Schwannoma and Neurofibroma. (2011) The Korean Journal of Pathology.
36. JY Park, Y Kang, KS Park, M Choe. Solitary Polypoid Ganglioneuroma of the Cecum. (2009) Journal of Korean Society of Coloproctology.